Most of these regulations now fall far short of the science-based approach mandated by U.S. regulatory policy.
In the years since, U.S. regulatory agencies have adapted their regulations several times but still have not kept pace with the rapid improvements in understanding the performance and safety of crops through biotechnology.9
Most of these regulations now fall far short of the science-based approach mandated by U.S. regulatory policy. Meanwhile, the EU has recognized its process-based approach’s failure and is trying to avoid repeating its errors while ensuring the safety of the next generation of innovations produced through gene editing.10